Unique ID issued by UMIN | UMIN000051237 |
---|---|
Receipt number | R000056964 |
Scientific Title | Comparison of the ability of Artifical intelligence-based computer-aided detection (CAD) systems and endoscopists to detect colorectal neoplastic lesions. |
Date of disclosure of the study information | 2023/06/02 |
Last modified on | 2023/12/02 09:15:50 |
Comparison of the ability of artifical intelligence-based computer-aided detection (CAD) systems and endoscopists to detect colorectal neoplastic lesions.
Comparison of the ability of CAD systems and endoscopists to detect colorectal neoplastic lesions.
Comparison of the ability of Artifical intelligence-based computer-aided detection (CAD) systems and endoscopists to detect colorectal neoplastic lesions.
Comparison of the ability of CAD systems and endoscopists to detect colorectal neoplastic lesions.
Japan |
colorectal polyp
Gastroenterology |
Others
NO
To identify the superiority of CAD and endoscopists' ability to detect colorectal neoplastic lesions.
Efficacy
Superiority of time taken by the endoscopist to detect colorectal neoplastic polyps versus by the CAD to detect colorectal neoplastic polyps (number of wins/losses)
Observational
18 | years-old | <= |
90 | years-old | >= |
Male and Female
All cases of colonoscopy performed from June 1st 2022 to July 31th 2022 by the study coordinator at Tokyo Women's Medical University hospital in which two types of videos were recorded simultaneously, one using the CAD function and the other not using it.
Endoscopists who view the videos will be selected from endoscopists who work in the Institute of Gastroenterology, or the Department of Digestive Endoscopy at Tokyo Women's Medical University Hospital and who perform colonoscopies on a daily basis. 3 experts who have performed more than 5000 colonoscopies and 3 beginners who have performed less than 500 colonoscopies will be selected.
Cases with poor preparation
Cases in which CAD indicated more than 5 colorectal polyps of 10 mm or less
Cases in which endoscopic procedures were performed including biopsy
Cases in which no neoplastic lesions were detected
Inflammatory bowel disease and polyposis
Cases with an examination time of 20 minutes or longer
46
1st name | Yoshitsugu |
Middle name | |
Last name | Misumi |
Tokyo Women's Medical University Hospital
Department of Digestive Endoscopy
162-8666
8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan.
+81333538111
yoshikft34@gmail.com
1st name | Yoshitsugu |
Middle name | |
Last name | Misumi |
Tokyo Women's Medical University Hospital
Department of Digestive Endoscopy
162-8666
8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan.
+81333538111
yoshikft34@gmail.com
Tokyo Women's Medical University Hospital
None.
Self funding
Tokyo Women's Medical University Hospital
8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan.
+81333538111
yoshikft34@gmail.com
NO
2023 | Year | 06 | Month | 02 | Day |
Unpublished
47
Completed
2023 | Year | 05 | Month | 31 | Day |
2023 | Year | 05 | Month | 31 | Day |
2023 | Year | 06 | Month | 01 | Day |
2023 | Year | 06 | Month | 10 | Day |
Study design
This study involves a single center, Tokyo Women's Medical University Hospital. Endoscopy videos are used to evaluate whether CAD EYE, an AI equipped colonoscope CAD system, is superior to endoscopists in its ability to detect colorectal neoplastic lesions, and to compare the times needed by CAD EYE and the endoscopists to detect tumors. This study approved by the ethics committee of Tokyo Women's Medical University. Informed consent was obtained from all patients for using the videos. Patients are free to withdraw consent at any time. In addition to the study coordinator, Endoscopist A, a total of six people participated in this study, three experts (>5000 colonoscopies) and three beginners (<500 colonoscopies).
Study population
The study will use colonoscopies performed by Endoscopist A at Tokyo Women's Medical University Hospital from June 1 to July 30, 2022, using a high- definition colonoscope and a high-definition monitor. We do not examine the symptoms, purpose of examination, age, or sex of any of the patients. The inclusion criteria are the presence of at least one neoplastic lesion (adenoma or adenocarcinoma) measuring<10mm. For the final determination of whether the lesion is neoplastic, the gold standard is CAD EYE's CADx diagnosis. Patients with poor pretreatment, with >5 neoplastic lesions, with inflammatory bowel disease, with polyposis, who underwent endoscopic procedures that include biopsies, and whose examination took>20 min will be excluded.
2023 | Year | 06 | Month | 02 | Day |
2023 | Year | 12 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056964
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |